These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Osteoclastogenesis in Abdominal Aortic Aneurysms: A New Therapeutic Target. Leung AD; Yamanouchi D Curr Drug Targets; 2018; 19(11):1233-1240. PubMed ID: 28950811 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms. Xu B; Xuan H; Iida Y; Miyata M; Dalman RL Curr Drug Targets; 2018; 19(11):1318-1326. PubMed ID: 29359665 [TBL] [Abstract][Full Text] [Related]
13. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Thompson RW; Baxter BT Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms. Thompson RW; Liao S; Curci JA Adv Dent Res; 1998 Nov; 12(2):159-65. PubMed ID: 9972142 [TBL] [Abstract][Full Text] [Related]
15. The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms. VAN KUIJK JP; FLU WJ; WITTEVEEN OP; VOUTE M; BAX JJ; POLDERMANS D J Cardiovasc Surg (Torino); 2009 Oct; 50(5):599-609. PubMed ID: 19741575 [TBL] [Abstract][Full Text] [Related]
16. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. Aoki H; Yoshimura K; Matsuzaki M J Mol Med (Berl); 2007 Oct; 85(10):1077-88. PubMed ID: 17522832 [TBL] [Abstract][Full Text] [Related]
17. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth. Yu J; Liu S; Huang J; Wang W Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546 [TBL] [Abstract][Full Text] [Related]
18. Fucoidan attenuates angiotensin II-induced abdominal aortic aneurysms through the inhibition of c-Jun N-terminal kinase and nuclear factor κB activation. Tsai SH; Wang JC; Liao WI; Hsu YJ; Lin CY; Liao MT; Huang PH; Lin SJ J Vasc Surg; 2018 Dec; 68(6S):72S-81S.e1. PubMed ID: 29290496 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy. Dale MA; Ruhlman MK; Baxter BT Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1746-55. PubMed ID: 26044582 [TBL] [Abstract][Full Text] [Related]